Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Net Margin Over TimeExpanding
Percentile Rank89
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
-85.54%
↑ 100% vs avg
Percentile
P89
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-19792.66%
Historical baseline
PeriodValueYoY Change
TTM-85.54%+15.8%
2024-101.60%+27.3%
2023-139.70%+28.3%
2022-194.71%-50.7%
2021-129.20%-87.7%
2020-68.84%+82.3%
2019-388.31%-1.2%
2018-383.75%+96.7%
2017-11567.34%+93.7%
2016-184867.67%-